Subscribe
pic-of-aippi-spc-and-ptes-story
17 September 2019Big PharmaSaman Javed

AIPPI World Congress 2019: SPC and PTEs around the world

This week at the AIPPI World Congress 2019, counsel discussed how supplementary protection certificates (SPC) and patent term extension (PTE) regulations differ across jurisdictions.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
No SPC crown for Royalty Pharma
10 July 2020   An attempt to obtain a supplementary protection certificate ended up raising the bar to achieving this coveted IP, as Joel Beevers and Michael Pears of Potter Clarkson explain.
Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
No SPC crown for Royalty Pharma
10 July 2020   An attempt to obtain a supplementary protection certificate ended up raising the bar to achieving this coveted IP, as Joel Beevers and Michael Pears of Potter Clarkson explain.
Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.

More on this story

Big Pharma
No SPC crown for Royalty Pharma
10 July 2020   An attempt to obtain a supplementary protection certificate ended up raising the bar to achieving this coveted IP, as Joel Beevers and Michael Pears of Potter Clarkson explain.
Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?